Fildesin injections 3 mg from Japan for chemotherapy (esophageal cancer, lung cancer, lymphoma, acute leukemia)
What are Fildesin injections 3 mg for chemotherapy?
The active principle of Fildesin injections is vindesine sulfate, an anti-mitotic and anti-microtubule alkaloid. It has been one of the most popular and important medicines in chemotherapy for more than 40 years. Although adverse effects may appear, Fildesin injections are very effective in fighting esophageal, lung, and acute leukemias, malignant lymphoma, and other types of cancer
Fildesin injections come in two different forms: a 1 mg and a 3 mg bottles. This product is a 3 mg bottle. Contact us if you require 1 mg.
Active principles: vindesine sulfate
Amount: 10 bottles
Maker: Nichi-iko Pharmaceutical Co., Ltd, Toyama, Japan
- acute leukemia (including blast crises of chronic myeloidleukemia),
- esophageal cancer,
- lung cancer,
- malignant lymphoma.
How to use
Patient should receive 1 intravenous injection per week. The content of the bottle should be diluted with distilled water or saline solutions in a ratio of 1 ml water/saline for every 1 mg of Fildesin injections. Your doctor can adjust the dosage according to symptoms and concomitant drugs.
For acute leukemia or malignant lymphoma: adults receive 0.06 mg of active principle per 1 kilogram of body weight. Children receive 0.07 to 0.01 mg per kilogram.
For lung cancer and esophageal carcinoma: adults should receive 0.06-0.09mg of the active principle per 1 kilogram of body weight.
Contraindications: do not use for pregnant or breastfeeding women.
If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.